Medical University of South Carolina- Investigational Drug Services — Charleston, South Carolina

Medical University of South Carolina- Investigational Drug Services is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina- Investigational Drug Services has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Acute Myeloid Leukemia.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina- Investigational Drug Services?

Medical University of South Carolina- Investigational Drug Services has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina- Investigational Drug Services conducted?

Medical University of South Carolina- Investigational Drug Services has 1 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, Acute Myeloid Leukemia.

Is Medical University of South Carolina- Investigational Drug Services accredited by Crixeo Health?

Medical University of South Carolina- Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical University of South Carolina- Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.